+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain tissue using P12201(SLC6A7 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P12201(SLC6A7 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The solute carrier family 6 member 7 (SLC6A7) is a sodium-dependent neurotransmitter transporter primarily responsible for the uptake of L-proline in the central nervous system. It belongs to the SLC6 transporter family, which includes key regulators of synaptic neurotransmission. SLC6A7 is expressed in specific brain regions, such as the hippocampus, amygdala, and cerebral cortex, and is implicated in modulating glutamatergic signaling and neuroplasticity. Its role in proline transport suggests potential involvement in neurological and psychiatric disorders, including schizophrenia, depression, and anxiety, as abnormal proline metabolism has been linked to cognitive dysfunction.

SLC6A7 antibodies are critical tools for studying the protein's expression, localization, and function in both physiological and pathological contexts. These antibodies enable researchers to detect SLC6A7 in tissue samples, cell lines, or experimental models using techniques like Western blotting, immunohistochemistry, or immunofluorescence. Recent studies have also explored SLC6A7's potential relevance in cancer, as altered expression has been observed in certain tumors. However, the exact mechanisms linking SLC6A7 to disease remain unclear, necessitating further research. Validated antibodies with high specificity are essential to avoid cross-reactivity with other SLC6 family members, ensuring accurate interpretation of experimental data. The development and application of SLC6A7 antibodies thus contribute to advancing our understanding of its biological significance and therapeutic potential.